Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Dexamethasone sodium phosphate powder injection and production method thereof

A technology of dexamethasone sodium phosphate and powder injection, which is applied in directions such as antidote, anti-inflammatory agent, powder delivery, etc., can solve the problems of difficulty in ensuring the stability of filling volume, adverse effects on medication safety, and low dosage of propylene glycol, etc. Achieve the effect of reducing loss, reducing energy consumption and reducing production costs

Inactive Publication Date: 2012-01-11
TIANJIN JINYAO GRP
View PDF2 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] It can be seen from this that although the amount of propylene glycol used in each dexamethasone sodium phosphate injection is not large, there are still certain risks, especially when used for a long time or in large quantities, the potential harm to the human body is relatively large
[0009] In addition to injections, currently commercially available dexamethasone sodium phosphate injections also have freeze-dried powder injections, which can avoid some of the problems caused by the above injections. However, the preparation of freeze-dried powder injections requires a large investment and high energy consumption. For dexamethasone For a commonly used drug such as sodium phosphate injection, the preparation of freeze-dried powder injection will greatly increase its production cost, and the preparation of powder injection will inevitably add various excipients, such as mannitol, lactose, etc. These excipients In addition to further increasing the cost of the preparation, the addition of the drug may also have a potential adverse effect on the safety of the drug
If the method of directly dispensing sterile raw materials is adopted, because the commonly used doses (1mg, 2mg, 5mg) of dexamethasone sodium phosphate are too small, it is difficult to ensure the stability of the loading under the conditions of existing preparation equipment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dexamethasone sodium phosphate powder injection and production method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Dexamethasone Sodium Phosphate 50g

[0031]Methanol to 1000ml

[0032] (1) Dissolve the prescribed amount of dexamethasone sodium phosphate in the prescribed amount of methanol, and stir until completely dissolved to obtain the medicinal solution (1).

[0033] (2) The liquid medicine (1) is filtered with a G6 vertically fused glass funnel, and the filtrate is ultrafiltered with a polyimide (PI) ultrafiltration membrane with a molecular weight cut-off of 6000, and filled into a 1ml vial with a micro-filler , each bottle is filled with 0.1ml, a total of 10,000 bottles are filled, and each bottle contains 5 mg of dexamethasone sodium phosphate.

[0034] (3) Put the vials filled in step (2) into a vacuum drying oven, slowly vacuum-dry them at room temperature (20°C), keep the internal pressure of the drying oven at 30kpa, and dry at a temperature of 35°C until methanol is almost After evaporating to dryness, raise the drying temperature to 50°C, apply vacuum to keep the p...

Embodiment 2

[0036] Dexamethasone Sodium Phosphate 20g

[0037] Methanol to 1000ml

[0038] (1) Dissolve the prescribed amount of dexamethasone sodium phosphate in the prescribed amount of methanol, and stir until completely dissolved to obtain the medicinal solution (1).

[0039] (2) The liquid medicine (1) is filtered with a G6 vertically fused glass funnel, and the filtrate is ultrafiltered with a polyimide (PI) ultrafiltration membrane with a molecular weight cut-off of 6000, and filled into a 1ml vial with a micro-filler , each bottle is filled with 0.1ml, a total of 10,000 bottles are filled, and each bottle contains 2mg of dexamethasone sodium phosphate.

[0040] (3) Put the vials filled in step (2) into a vacuum drying oven, slowly vacuum-dry them at room temperature (20°C), keep the internal pressure of the drying oven at 25kpa, and dry at a temperature of 30°C until methanol is almost After evaporating to dryness, raise the drying temperature to 50°C, apply vacuum to keep the p...

Embodiment 3

[0042] Dexamethasone Sodium Phosphate 10g

[0043] 95% ethanol to 1000ml

[0044] (1) Dissolve the prescribed amount of dexamethasone sodium phosphate in the prescribed amount of 95% ethanol, and stir until completely dissolved to obtain the medicinal solution (1).

[0045] (2) The liquid medicine (1) is filtered with a G6 vertically fused glass funnel, and the filtrate is ultrafiltered with a polyimide (PI) ultrafiltration membrane with a molecular weight cut-off of 6000, and filled into a 1ml vial with a micro-filler , each bottle is filled with 0.1ml, a total of 10,000 bottles are filled, and each bottle contains 1mg of dexamethasone sodium phosphate.

[0046] (3) Put the vials filled in step (2) into a vacuum drying oven, slowly vacuum-dry them at room temperature (20°C), keep the internal pressure of the drying oven at 25kpa, and dry at a temperature of 30°C until ethanol is almost After evaporating to dryness, vacuumize to keep the pressure in the drying oven at 5 kap,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a dexamethasone sodium phosphate powder injection and a production method thereof. The method for preparing the dexamethasone sodium phosphate powder injection comprises the following steps of: 1) dissolving dexamethasone sodium phosphate in an organic solvent to obtain a medicinal solution (1); and 2) performing sterilization and pyrogen removal on the medicinal solution (1), directly filling into an injection bottle, removing the organic solvent from the filled injection bottle by adopting a reduced-pressure drying method, capping and packaging, and recovering the organic solvent at the same time.

Description

Technical field: [0001] The invention relates to a corticosteroid injection, in particular to a production process of dexamethasone sodium phosphate powder injection. Background technique: [0002] Dexamethasone sodium phosphate (DEXAMETHASONE SODIUM PHOSPHATE, referred to as "de sodium") is an adrenocortical hormone drug. It has anti-inflammatory, anti-allergic, anti-rheumatic and immunosuppressive effects, and is widely used in the treatment of allergic and autoimmune inflammatory diseases. Such as connective tissue disease, active rheumatism, rheumatoid arthritis, lupus erythematosus, severe bronchial asthma, severe dermatitis, ulcerative colitis, acute leukemia, etc. It is also used for some serious infections, poisoning, and malignant lymphoma. treat. The common dosage form is sodium desalination injection. Due to the different production processes of desalination, the excipients used in the formulations of domestic and foreign desalination injections are also differ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/14A61K31/661A61P37/08A61P37/02A61P19/04A61P29/00A61P19/02A61P11/06A61P17/00A61P1/04A61P35/02A61P31/00A61P39/02A61P35/00
Inventor 孙亮张其婉陈松
Owner TIANJIN JINYAO GRP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products